SBIR/STTR Research Award
THE PRIMARY OBJECTIVE OF THE PROPOSED PHASE I WORK IS TO FURTHER DEVELOP A PROOF-OF-CONCEPT (POC) MACHINE LEARNING APPROACH TO DETECT ILLEGAL OPIOID SELLERS AND DEVELOP IT INTO AN MVP THAT CAN COLLEC
Award amount
$224,864Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- S-3 RESEARCH LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- LELZHK767GF3
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
The primary objective of the proposed Phase I work is to further develop a proof of conceptPOCmachine learning approach to detect illegal opioid sellers and develop it into an MVP that can collect information onas well as identifycategorizeand enable data visualization and reporting of illegal online pharmacies and drug dealers selling opioids on popular social media platforms
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Co-designing a mobile tool to improve diversity and inclusivity in AD/ADRD trial participation
- WeeDetection: Multi-platform Detection System to Identify and Report Illegal Sales of Cannabis-derived Products
- SUD-t Map: A Big Data Digital Platform to Identify and Characterize SUD Treatment Opportunities to Address Health Disparities
- THE PRIMARY OBJECTIVE OF THE PROPOSED PHASE II WORK IS TO EXPAND THE PRODUCT OFFERING AND SUCCESSFULLY COMMERCIALIZE THE MVP THAT WAS SUCCESSFULLY DEV
- THE PRIMARY OBJECTIVE OF THE PROPOSED PHASE I WORK IS TO FURTHER DEVELOP A PROOF-OF-CONCEPT(POC) MACHINE LEARNING APPROACH TO DETECT ILLEGAL OPIOID SE
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
6 SBIR/STTR records share this UEI (2019–2025). Reported award amounts total $2,834,925. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services